序号 |
标题 |
次数 |
作者 |
发布时间 |
78256 |
单抗MN14-DOTA 大环配体DOTA修饰单抗MN14 |
101 |
h |
2024-12-18 |
78257 |
Oleoyl-Gly-Lys-N-(m-PEG11)烷基链 |
101 |
zyl |
2024-12-18 |
78258 |
DOTA-Gd-Au PENPs mPEG修饰钆螯合剂包裹金纳米粒 |
107 |
h |
2024-12-18 |
78259 |
Fmoc-Gly3-Val-Cit-PAB-PNP烷基链定制 |
123 |
zyl |
2024-12-18 |
78260 |
cas:1268488-70-5,Bis-PEG9-acid,4,7,10,13,16,19,22,25,28-九氧杂三十一烷-1,31-二酸 |
85 |
kx |
2024-12-18 |
78261 |
DOTA-SSTa DOTA修饰SSTa抑制剂 |
158 |
h |
2024-12-18 |
78262 |
CAS号为1350456-56-2的Fmoc-Val-Cit-PAB-MMAE |
93 |
WYQ |
2024-12-18 |
78263 |
CAS号为2353409-69-3的Mal-PEG8-Val-Cit-PAB-MMAE |
121 |
WYQ |
2024-12-18 |
78264 |
cy5.5-QS cy5.5荧光标记VEGF125-136小肽QS |
92 |
h |
2024-12-18 |
78265 |
THP-SS-PEG1-Boc CAS:1807503-88-3 |
97 |
zyl |
2024-12-18 |
78266 |
cas:132178-37-1,Propargyl-C1-NHS ester,2, 5-二氧代吡咯烷-1-基 戊-4-炔酸酯 |
87 |
kx |
2024-12-18 |
78267 |
CAS号为646502-53-6的MC-Val-Cit-PAB-MMAE |
108 |
WYQ |
2024-12-18 |
78268 |
DOTA-ECL1i 7-氨基酸CCR2结合肽[外环1变型(ECL1i)]偶联DOTA大环配体 |
128 |
h |
2024-12-18 |
78269 |
MC-EVCit-PAB-MMAE(CAS号:2873452-49-2) |
88 |
WYQ |
2024-12-18 |
78270 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
98 |
h |
2024-12-18 |
78271 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
96 |
h |
2024-12-18 |
78272 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
107 |
h |
2024-12-18 |
78273 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
99 |
h |
2024-12-18 |
78274 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
92 |
h |
2024-12-18 |
78275 |
Ald-CH2-PEG2-CH2CO2 tBu ester,cas:2230956-95-1 |
107 |
zyl |
2024-12-18 |
78276 |
cas:796073-55-7,4-Methyl-4-(methyldisulfanyl)pentanoic acid,4-甲基-4-(甲基二硫烷基)戊酸 |
81 |
kx |
2024-12-18 |
78277 |
Ad-PG-FA 线性聚缩水甘油修饰叶酸靶向分子 |
101 |
h |
2024-12-18 |
78278 |
三嵌段共聚物PCL-PEEGE-PCL |
199 |
h |
2024-12-18 |
78279 |
炔基功能化的聚乙二醇(alkynyl-PEG) |
81 |
h |
2024-12-18 |
78280 |
cas:784105-33-5,Amino-PEG3-C2-acid,3-[2-[2-(2-氨基乙氧基)乙氧基]乙氧基]丙酸 |
97 |
kx |
2024-12-18 |
78281 |
Phthalamidoxy-PEG2-CH2-ald,cas:1415246-44-4 |
88 |
zyl |
2024-12-18 |
78282 |
甘草次酸偶联Gd-DOTA(GGD) |
79 |
h |
2024-12-18 |
78283 |
Fmoc-NH-PEG6-CH2COOH,cas:437655-96-4 |
78 |
zyl |
2024-12-18 |
78284 |
cas:557756-85-1,Fmoc-NH-PEG4-CH2CH2COOH,5,8,11,14-四氧杂-2-氮杂十七烷二酸1-(9H-芴-9-基甲基)酯 |
113 |
kx |
2024-12-18 |
78285 |
DOTA-3-酪氨酰基-奥曲肽 DOTA-TATE |
96 |
h |
2024-12-18 |
78286 |
DBCO-DOTA-Eu 叠氮功能化修饰OTA-Eu |
196 |
h |
2024-12-18 |
78287 |
HO-PEG10-CH2COOtBu |
108 |
zyl |
2024-12-18 |
78288 |
cas:1026987-94-9,DUPA(OtBu)-OH |
103 |
kx |
2024-12-18 |
78289 |
NOTA/DFO-MAL-Cys-MZHER2 亲和体Cys-MZHER2偶联螯合剂NOTA/DFO-MAL |
108 |
h |
2024-12-18 |
78290 |
N-DBCO-N-bis(PEG2-amide-PEG4-Val-Cit-PAB-MMAE) |
109 |
WYQ |
2024-12-18 |
78291 |
Propargyl-PEG2-CH2CO2-NHS ester,cas:2244145-13-7 |
103 |
zyl |
2024-12-18 |
78292 |
NHS ester-PEG4-Val-Cit-PAB-MMAE,(二苯并环辛炔N-羟基琥珀酰亚胺酯) |
209 |
WYQ |
2024-12-18 |
78293 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-1-柰丙氨酸-奥曲肽 DOTA-NOC |
95 |
h |
2024-12-18 |
78294 |
CAS号为1350456-56-2的Fmoc-Val-Cit-PAB-MMAE |
91 |
WYQ |
2024-12-18 |
78295 |
Azido-PEG3-CH2CO2Me,cas:1253389-31-9 |
92 |
zyl |
2024-12-18 |
78296 |
cas:60444-78-2,Ald-Ph-NHS ester,4-甲酰苯甲酸N-琥珀酰亚胺酯 |
150 |
kx |
2024-12-18 |
78297 |
荧光染料sulfo-Cy5.5-NHS酯 |
143 |
h |
2024-12-18 |
78298 |
DOTA-NVVRQ DOTA-TMTP1 双功能螯合剂DOTA偶联多肽TMTP1(NVVRQ) |
114 |
h |
2024-12-18 |
78299 |
CAS号为2353409-69-3的Mal-PEG8-Val-Cit-PAB-MMAE |
171 |
WYQ |
2024-12-18 |
78300 |
聚DOTA新型树枝状分子(PDOTA) |
125 |
h |
2024-12-18 |